Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

BACKGROUND: Allergen-specific immunotherapy represents the only disease-modifying treatment for allergic diseases. We and others have previously demonstrated that intralymphatic immunotherapy (ILIT), a less time-consuming alternative to conventional subcutaneous immunotherapy (SCIT), is safe and eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Hylander, Terese, Larsson, Olivia, Petersson-Westin, Ulla, Eriksson, Mia, Kumlien Georén, Susanna, Winqvist, Ola, Cardell, Lars-Olaf
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728811/
https://ncbi.nlm.nih.gov/pubmed/26817454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0324-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados